Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The relationship between upper leg muscle strength and walking capacity in persons with multiple sclerosis.
Long term benefit of multiple sclerosis treatment: an investigation using a novel data collection technique.
Impact of Repeated Topical-Loaded Manganese-Enhanced MRI on the Mouse Visual System.
Cost-sharing and initiation of disease-modifying therapy for multiple sclerosis.
Control of TH17 cells occurs in the small intestine.
[Optic neuropathy and meningioma: A diagnostic trap.]
25-Hydroxycholecalciferol status in plasma is linearly correlated to daily summer pasture time in cattle at 56°N.
Whole-Brain Diffusion Tensor Imaging in Correlation to Visual-Evoked Potentials in Multiple Sclerosis: A Tract-Based Spatial Statistics Analysis.
Potentiation of High Voltage-Activated Calcium Channels by 4-Aminopyridine Depends upon Subunit Composition.
Papaverine inhibits lipopolysaccharide-induced microglial activation by suppressing NF-κB signaling pathway.
Alemtuzumab Therapy for Multiple Sclerosis.
Effect of open label pulse cyclophosphamide therapy on MRI measures of disease activity in five patients with refractory relapsing-remitting multiple sclerosis.
Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned.
Does risk stratification decrease the risk of natalizumab-associated PML? Where is the evidence?
Substance Name: MEDI 551
Prevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosis.
Nerve Conduction Velocity Is Regulated by the Inositol Polyphosphate-4-Phosphatase II Gene.
Randomised natalizumab discontinuation study: taper protocol may prevent disease reactivation.
Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis.
Purified and synthetic Alzheimer's amyloid beta (Aβ) prions.
Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status.
Development of nucleic acid drugs for neurological disorders.
Analysis of T2 intensity by magnetic resonance imaging of deep gray matter nuclei in multiple sclerosis patients: effect of immunomodulatory therapies.
Multiple sclerosis: The potassium channel KIR4.1-a potential autoantigen in MS.
Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica.

Pages